Adaptive Biotechnologies Corp(ADPT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ADPT Adaptive Biotechnologies Corp

盘后交易 07-24 17:30:16 EDT

22.27

-0.04

-0.18%

盘后22.70

+0.43+1.93%

17:06 EDT

最高22.77	最低21.83	成交量281.99万
今开22.56	昨收22.31	日振幅4.21%
总市值35.58亿	流通市值28.06亿	总股本1.60亿
成交额6,273万	换手率2.24%	流通股本1.26亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ADPT","market":"US","secType":"STK","nameCN":"Adaptive Biotechnologies Corp","latestPrice":22.27,"timestamp":1784923200000,"preClose":22.31,"halted":0,"volume":2819934,"hourTrading":{"tag":"盘后","latestPrice":22.7,"preClose":22.27,"latestTime":"17:06 EDT","volume":163246,"amount":3633494.2068640003,"timestamp":1784927211034,"change":0.43,"changeRate":0.019308,"amplitude":0.020777},"delay":0,"changeRate":-0.0017929179740026513,"floatShares":126000000,"shares":159760700,"eps":-0.325352,"marketStatus":"盘后交易","change":-0.04,"latestTime":"07-24 17:30:16 EDT","open":22.56,"high":22.77,"low":21.83,"amount":62731569.339972,"amplitude":0.042134,"askPrice":22.7,"askSize":88,"bidPrice":21.84,"bidSize":91,"shortable":3,"etf":0,"ttmEps":-0.325352,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1784937600000},"marketStatusCode":4,"adr":0,"listingDate":1561608000000,"exchange":"NASDAQ","adjPreClose":22.31,"preHourTrading":{"tag":"盘前","latestPrice":21.5187,"preClose":22.31,"latestTime":"07:55 EDT","volume":25,"amount":559.3587,"timestamp":1784894114807,"change":-0.7913,"changeRate":-0.035468,"amplitude":0.039951},"postHourTrading":{"tag":"盘后","latestPrice":22.7,"preClose":22.27,"latestTime":"17:06 EDT","volume":163246,"amount":3633494.2068640003,"timestamp":1784927211034,"change":0.43,"changeRate":0.019308,"amplitude":0.020777},"volumeRatio":1.007279,"impliedVol":0.715,"impliedVolPercentile":0.3147},"requestUrl":"/m/hq/s/ADPT","defaultTab":"news","newsList":[{"id":"1150630628","title":"财报前瞻｜Adaptive Biotechnologies Corp本季度营收预计增长33.37%，机构观点待披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1150630628","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150630628?lang=zh_cn&edition=full","pubTime":"2026-07-22 14:18","pubTimestamp":1784701086,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies Corp将于2026年07月29日发布财报，市场关注营收恢复与亏损收窄的进展。市场一致预期显示，本季度公司营收预计为美元6,588.57万，同比增长33.37%；预计调整后每股收益为-0.13美元，同比改善43.98%；预计EBIT为美元-2,056.48万，同比改善41.39%。部分研判指出，若公司能够在本季度维持营收同比30.00%以上增长并保持约40.27%的毛利率水平，同时控制费用率，股东回报的时间表将更为清晰。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Adaptive Biotechnologies Corp本季度营收预计增长33.37%，机构观点待披露","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139782960","title":"财报前瞻｜Adaptive Biotechnologies Corp本季度营收预计增42.58%，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1139782960","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139782960?lang=zh_cn&edition=full","pubTime":"2026-04-28 14:03","pubTimestamp":1777356195,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies Corp将于2026年05月05日发布财报，本文汇总市场一致预期与核心看点。市场一致预期本季度公司营收为6,085.00万美元，同比增长42.58%；调整后每股收益为-0.16美元，同比增长45.30%；EBIT为-2,452.27万美元，同比增长43.85%，公司层面暂无本季度毛利率与净利率的具体预测数据。结合一致预期，本季度营收同比增速预计达到42.58%，若MRD业务延续放量，收入高增将与规模效应共同推动亏损收窄。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Adaptive Biotechnologies Corp本季度营收预计增42.58%，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155755231","title":"异动解读 | 发布积极财务指引，Adaptive Biotechnologies盘后大涨6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=1155755231","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155755231?lang=zh_cn&edition=full","pubTime":"2026-02-06 05:51","pubTimestamp":1770328279,"startTime":"0","endTime":"0","summary":"生物技术公司Adaptive Biotechnologies Corp（ADPT）今日盘后股价大幅上涨6.25%，引起了市场关注。消息面上，公司于盘后交易时段前发布了最新的财务指引。一方面，公司预计其微小残留病（MRD）业务板块在2024财年的全年营收将达到2.55亿美元至2.65亿美元，显示了该核心业务强劲的增长预期。另一方面，公司同时给出了全年运营开支（包含营收成本）的指引，预计将控制在3.5亿美元至3.6亿美元之间。市场分析认为，明确的营收增长前景与可控的成本预期相结合，增强了投资者对公司未来盈利能力的信心，从而推动了股价在盘后显著走高。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ADPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152278122","title":"Adaptive Biotechnologies预计MRD业务全年营收将达2.55亿至2.65亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1152278122","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152278122?lang=zh_cn&edition=full","pubTime":"2026-02-06 05:30","pubTimestamp":1770327035,"startTime":"0","endTime":"0","summary":"生物技术公司Adaptive Biotechnologies Corp（ADPT）公布其微小残留病（MRD）业务板块的全年营收指引。该公司预计，该业务在2024财年的总收入将介于2.55亿美元至2.65亿美元之间。这一预测反映了公司对MRD检测市场持续增长及自身商业化执行能力的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADPT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163775372","title":"Adaptive Biotechnologies预计全年运营开支（含营收成本）介于3.5亿至3.6亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1163775372","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163775372?lang=zh_cn&edition=full","pubTime":"2026-02-06 05:27","pubTimestamp":1770326846,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies Corp（ADPT）发布最新财务指引，预计其全年运营开支——其中包含营收成本——将落在3.5亿美元至3.6亿美元的区间内。\n这一预测反映了公司在研发投入、商业拓展及日常运营方面的综合支出水平，为市场提供了明确的成本管控预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ADPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197379224","title":"财报前瞻 ｜Adaptive Biotechnologies Corp本季度营收预计增29.02%，机构观点偏正面","url":"https://stock-news.laohu8.com/highlight/detail?id=1197379224","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197379224?lang=zh_cn&edition=full","pubTime":"2026-01-29 11:19","pubTimestamp":1769656774,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies Corp将于2026年02月05日发布财报，市场关注本季度收入改善与利润修复节奏，以及主营微小残留病变服务的增长质量与盈利结构变化。- 一致预期显示，本季度Adaptive Biotechnologies Corp总收入预计为59,391,430美元，同比增29.02%；预计调整后每股收益为-0.18美元，同比改善29.27%；预计EBIT为-26,180,330美元，同比改善30.83%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻 ｜Adaptive Biotechnologies Corp本季度营收预计增29.02%，机构观点偏正面","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518322001","title":"Adaptive Biotechnologies Corporation盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518322001","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518322001?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:08","pubTimestamp":1741615711,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时08分，Adaptive Biotechnologies Corporation股票出现异动，股价快速下挫5.17%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃，换手率分别为3203.98%、694.50%、99.94%，振幅较大的相关个股有Scisparc Ltd.、Pmgc Holdings Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为40.24%、32.14%、30.40%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220831a26a32b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220831a26a32b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517165580","title":"Adaptive Biotechnologies Corporation盘中异动 早盘急速下跌5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517165580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517165580?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:34","pubTimestamp":1741271641,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时34分，Adaptive Biotechnologies Corporation股票出现异动，股价快速下挫5.53%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体跌幅为0.64%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223401abeb786c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223401abeb786c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517102949","title":"Adaptive Biotechnologies Corporation股价重挫14.53% 市值跌1.5亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517102949","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517102949?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185062,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分，Adaptive Biotechnologies Corporation股票出现波动，股价急速下跌14.53%。截至发稿，该股报6.94美元/股，成交量142.435万股，换手率0.96%，振幅0.31%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为0.08%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223103a260c6eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223103a260c6eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516722206","title":"Adaptive Biotechnologies Corporation盘中异动 大幅下跌5.01%报7.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516722206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516722206?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098754,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，Adaptive Biotechnologies Corporation股票出现异动，股价急速下跌5.01%。截至发稿，该股报7.69美元/股，成交量4.0044万股，换手率0.03%，振幅1.81%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为0.25%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503042232349639449a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503042232349639449a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514859250","title":"Adaptive Biotechnologies Corporation盘中异动 早盘快速上涨5.11%报8.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514859250","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514859250?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:48","pubTimestamp":1740581323,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时48分，Adaptive Biotechnologies Corporation股票出现异动，股价大幅上涨5.11%。截至发稿，该股报8.85美元/股，成交量9.5112万股，换手率0.06%，振幅4.16%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体跌幅为0.28%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226224843abddf16d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226224843abddf16d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514016839","title":"Adaptive Biotechnologies Corporation盘中异动 早盘急速下挫5.46%报7.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514016839","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514016839?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:32","pubTimestamp":1740497541,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时32分，Adaptive Biotechnologies Corporation股票出现异动，股价大幅下跌5.46%。截至发稿，该股报7.96美元/股，成交量25.6247万股，换手率0.17%，振幅6.15%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为0.78%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502252332229630008a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502252332229630008a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512387165","title":"Adaptive Biotechnologies Corporation盘中异动 急速拉升5.04%报8.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512387165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512387165?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:33","pubTimestamp":1739889180,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时33分，Adaptive Biotechnologies Corporation股票出现波动，股价急速上涨5.04%。截至发稿，该股报8.75美元/股，成交量4.7002万股，换手率0.03%，振幅3.00%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为0.11%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223301abd3af7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223301abd3af7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511670403","title":"Adaptive Biotechnologies Corporation2024财年实现净利润-1.59亿美元，同比增加29.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511670403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511670403?lang=zh_cn&edition=full","pubTime":"2025-02-16 00:00","pubTimestamp":1739635244,"startTime":"0","endTime":"0","summary":"2月16日，Adaptive Biotechnologies Corporation公布财报，公告显示公司2024财年净利润为-1.59亿美元，同比增加29.33%；其中营业收入为1.79亿美元，同比增加5.29%，每股基本收益为-1.08美元。从资产负债表来看，Adaptive Biotechnologies Corporation总负债3.37亿美元，其中短期债务10.24百万美元，资产负债比为1.60，流动比率为0.03。机构评级：截至2025年2月16日，当前有7家机构对Adaptive Biotechnologies Corporation目标价做出预测，其中目标均价为9.00美元，其中最低目标价为7.00美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216000049a24729a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216000049a24729a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155355441","title":"异动解读 | Adaptive Biotechnologies Corp盘中大涨9.93%,机构看好前景上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1155355441","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155355441?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:16","pubTimestamp":1739474195,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies Corp(ADPT)股价今日盘中大涨9.93%,引发市场关注。\n\n股价上涨主要受到机构评级目标价上调的利好消息驱动。投行Scotiabank维持对ADPT的评级为\"跑赢大盘\",并将目标价从10美元上调至12美元。此前,ADPT在生物技术行业内表现出较强的发展势头。\n\n作为一家专注于免疫驱动医学的生物科技公司,ADPT的临床诊断产品clonoSEQ已获FDA批准,可用于检测和监测多种血液肿瘤患者的最小残留病情。ADPT正着力将该产品推广至更广泛的淋巴癌适应症。公司在血液肿瘤诊断领域的创新有望为长期增长注入新动能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Adaptive Biotechnologies Corp盘中大涨9.93%,机构看好前景上调目标价","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ADPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511951579","title":"Scotiabank：维持Adaptive Biotechnologies(ADPT.US)评级，由跑赢大盘调整至跑赢大盘评级, 目标价由10.00美元调整至12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511951579","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511951579?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:11","pubTimestamp":1739473875,"startTime":"0","endTime":"0","summary":"Scotiabank：维持Adaptive Biotechnologies(ADPT.US)评级，由跑赢大盘调整至跑赢大盘评级, 目标价由10.00美元调整至12.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/14031148150865.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ADPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511524052","title":"Adaptive Biotechnologies Corporation盘中异动 早盘急速上涨5.03%报7.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511524052","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511524052?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:43","pubTimestamp":1739461435,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时43分，Adaptive Biotechnologies Corporation股票出现波动，股价大幅拉升5.03%。截至发稿，该股报7.93美元/股，成交量32.835万股，换手率0.22%，振幅7.35%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为0.50%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213234356a244bb18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213234356a244bb18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179443604","title":"Adaptive Biotechnologies 2024年第四季度GAAP每股亏损$(0.23)优于预期$(0.26)，销售额$47.459百万超过预期$46.034百万","url":"https://stock-news.laohu8.com/highlight/detail?id=1179443604","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179443604?lang=zh_cn&edition=full","pubTime":"2025-02-12 05:12","pubTimestamp":1739308350,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies  报告季度每股亏损$，优于分析师共识预期的$，超出11.54%。相比去年同期的$45.784百万，销售额增长了3.66%。以上内容来自Benzinga Earnings专栏，原文如下：Adaptive Biotechnologies  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 11.54 percent.  The company reported quarterly sales of $47.459 million which beat the analyst consensus estimate of $46.034 million by 3.09 percent.  This is a 3.66 percent increase over sales of $45.784 million the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Adaptive Biotechnologies 2024年第四季度GAAP每股亏损$(0.23)优于预期$(0.26)，销售额$47.459百万超过预期$46.034百万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510869382","title":"Adaptive Biotechnologies Corporation盘中异动 股价大跌5.31%报7.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510869382","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510869382?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:05","pubTimestamp":1739199908,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时05分，Adaptive Biotechnologies Corporation股票出现异动，股价急速下跌5.31%。截至发稿，该股报7.42美元/股，成交量26.2473万股，换手率0.18%，振幅5.35%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为0.27%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210230509961e0735&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210230509961e0735&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509960287","title":"Adaptive Biotechnologies Corporation盘中异动 快速上涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509960287","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509960287?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:51","pubTimestamp":1738767095,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时51分，Adaptive Biotechnologies Corporation股票出现异动，股价急速拉升5.29%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为1.60%。其相关个股中，Oragenics Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Oragenics Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3540.20%、1029.52%、654.81%，振幅较大的相关个股有Oragenics Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Pasithea Therapeutics Corp.，振幅分别为59.80%、54.05%、37.50%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205225135a23a7f68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205225135a23a7f68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.adaptivebiotech.com","stockEarnings":[{"period":"1week","weight":0.0095},{"period":"1month","weight":0.2948},{"period":"3month","weight":0.5778},{"period":"6month","weight":0.2027},{"period":"1year","weight":1.0524},{"period":"ytd","weight":0.3738}],"compareEarnings":[{"period":"1week","weight":-0.0167},{"period":"1month","weight":0.0063},{"period":"3month","weight":0.034},{"period":"6month","weight":0.071},{"period":"1year","weight":0.1639},{"period":"ytd","weight":0.0825}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Adaptive Biotechnologies Corporation于2009年9月8日在华盛顿州注册成立。公司正通过利用适应性免疫系统的固有生物学，向疾病的诊断和治疗转变，推进免疫驱动医学领域。该公司认为，适应性免疫系统是大自然对大多数疾病进行的最精细的诊断和治疗，但无法解码使医学界无法充分利用其能力。该公司的免疫医学平台应用专有技术来读取患者免疫系统的多种遗传密码，并准确了解如何检测和治疗该患者的疾病。该公司的免疫医学平台应用专有技术来读取患者免疫系统的多种遗传密码，并准确了解如何检测和治疗该患者的疾病。该公司在动态临床免疫组学数据库中捕捉到这些见解，该数据库以计算生物学和机器学习为基础，用于开发和商业化公司正在为每位患者量身定制的临床产品和服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.006662},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.034164},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.108302},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.084119},{"month":5,"riseRate":0.571429,"avgChangeRate":0.103614},{"month":6,"riseRate":0.857143,"avgChangeRate":0.145465},{"month":7,"riseRate":0.5,"avgChangeRate":0.004099},{"month":8,"riseRate":0.571429,"avgChangeRate":0.074393},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.065733},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.030408},{"month":11,"riseRate":0.714286,"avgChangeRate":0.049327},{"month":12,"riseRate":0.714286,"avgChangeRate":0.032336}],"exchange":"NASDAQ","name":"Adaptive Biotechnologies Corp","nameEN":"Adaptive Biotechnologies Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Adaptive Biotechnologies Corp(ADPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Adaptive Biotechnologies Corp(ADPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Adaptive Biotechnologies Corp,ADPT,Adaptive Biotechnologies Corp股票,Adaptive Biotechnologies Corp股票老虎,Adaptive Biotechnologies Corp股票老虎国际,Adaptive Biotechnologies Corp行情,Adaptive Biotechnologies Corp股票行情,Adaptive Biotechnologies Corp股价,Adaptive Biotechnologies Corp股市,Adaptive Biotechnologies Corp股票价格,Adaptive Biotechnologies Corp股票交易,Adaptive Biotechnologies Corp股票购买,Adaptive Biotechnologies Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Adaptive Biotechnologies Corp(ADPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Adaptive Biotechnologies Corp(ADPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}